Schedule 13G ownership disclosure
ProQR Therapeutics NV
Ordinary Shares, nominal value 0.04 euro per share · CUSIP: N71542109
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Adage Capital Management, L.P.
Shares: 6,601,938.00 · Class: 6.27%
- Robert Atchinson
Shares: 6,601,938.00 · Class: 6.27%
- Phillip Gross
Shares: 6,601,938.00 · Class: 6.27%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-003504
- Form type
- SCHEDULE 13G/A
- Filer
- Adage Capital Management, L.P.
- CIK
- CIK 1535978
- Filed
- Aug 12, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership